Cost Benefits

Improve Patient Outcomes. Improve Your Bottom Line.

As the Centers for Medicare & Medicaid Services (CMS) continues to transform from a passive payer to an active purchaser of higher-value health care services, hospitals need to adopt programs and strategies to improve patient outcomes and lower healthcare costs. How your hospital effectively identifies and treats bloodstream infections can impact your performance measures under the  Hospital-acquired Conditions (HAC) Program, Hospital Value-Based Purchasing, Hospital Inpatient Quality Reporting Program, and the Hospital Readmissions Reduction Program. Rapid diagnostics and quality antimicrobial stewardship can not only improve performance and reduce costs, it can improve patient outcomes by empowering physicians with better clinical information for targeted therapy or discontinuation of expensive and unnecessary antibiotic use that can lead to adverse events or antimicrobial resistance.

AdvanDx can play a key role in helping hospitals meet performance measures set forth in the Affordable Care Act. Our platform can aid in:
  • Rapid targeted antimicrobial therapy to patients with central line bloodstream infections (CLBSI) and Sepsis, a critical reimbursement measurement.
  • De-escalation of inappropriate antibiotic use to reduce adverse events and antimicrobial resistance.
  • Improved patient outcomes and experiences to get patients home faster and lower re-admission.

Clinical studies have shown that incorporating our PNA technology into hospitals led to 1) faster time to appropriate therapy, 2) shorter lengths of stay (LOS), 3) lower hospital costs per patient, 4) and reduction in antimicrobial use.1,2

Find out how AdvanDx can support your hospital in reducing healthcare costs and improving patients outcomes.

1. Forrest et al. Antimicro Chemo 2006; 58(1):154-158.
2. Forrest et al. Antimicrob Agents Chemo 2008; 52(10):3558-3563.